<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>Sense About Science</title></head><body><div><p style="margin:0pt"><span style="font-family:Arial; font-size:11pt">&#xa0;</span></p><p style="font-size:12pt; line-height:115%; margin:0pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Written evidence </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">from Sense About Science (GMC0021)</span></p><p style="font-size:12pt; line-height:115%; margin:0pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="font-size:12pt; line-height:115%; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Executive summary: </span></p><p style="font-size:12pt; line-height:115%; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">We believe that the </span><span style="font-family:'Times New Roman'; font-size:12pt">General Medical Council</span><span style="font-family:'Times New Roman'; font-size:12pt"> should have a role in ensuring that doctors work</span><span style="font-family:'Times New Roman'; font-size:12pt">ing on clinical trials or who worked on a clinical trial in the past on any treatment in current use ensures that the clinical trial has been registered and a summary of the findings is publicly available. </span></p><p style="font-size:12pt; line-height:115%; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal; line-height:115%; margin:0pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Sense About Science is a charity that equips peo</span><span style="font-family:'Times New Roman'; font-size:12pt">ple to make sense of science and evidence. We are a source of information, respond to misinformation and we champion research and high quality evidence. We do this working with over 6,000 scientists and researchers and hundreds of organisations from scienc</span><span style="font-family:'Times New Roman'; font-size:12pt">e and medicine and from across civil society. </span></li></ol><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal; line-height:115%; margin:0pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">We are co-founders of the AllTrials campaign along with </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic">BMJ</span><span style="font-family:'Times New Roman'; font-size:12pt">, </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic">PLOS</span><span style="font-family:'Times New Roman'; font-size:12pt">, Cochrane Collaboration, James Lind Initiative, Centre for Evidence Based Medicine, Ben Goldacre and, in the US,</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:12pt">Dartmouth’s Geisel School of </span><span style="font-family:'Times New Roman'; font-size:12pt">Medicine and the Dartmouth Institute for Health Policy &amp; Clinical Practice. </span></li></ol><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 18pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal; line-height:115%; margin:5pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Patients, researchers, pharmacists, doctors and regulators everywhere will benefit from publication of clinical trial results. </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal">Thousands of clinical trials have not reported their</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal"> results; some have not even been registered. Information on what was done and what was found in these trials could be lost forever to doctors and researchers, leading to bad treatment decisions, missed opportunities for good medicine, and trials being rep</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal">eated. This is what led to the </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal">AllTrials campaign. </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal">All trials past and present should be registered, and the full methods and summary results reported. The AllTrials campaign is calling on governments, regulators and research bodies to implement measures t</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal">o achieve</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal">this.</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold"> </span></li></ol><p style="font-size:12pt; line-height:115%; margin:5pt 0pt 0pt 18pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">&#xa0;</span></p><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal; line-height:115%; margin:0pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">The campaign is supported by 60,000 people and more than 400 organisations worldwide, including pharmaceutical companies, regulators, medical and scientific bodies, Universities, research funders a</span><span style="font-family:'Times New Roman'; font-size:12pt">nd more than 150 patient groups </span><span style="font-family:'Times New Roman'; font-size:12pt">representing around 350 million patients.</span></li></ol><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal; line-height:115%; margin:0pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Medical associations that support the campaign include the British Medical Association and the National Physicians Alliance in the US, nine medical Royal Colleges and the Academy of Medical Royal Colleges; medical</span><span style="font-family:'Times New Roman'; font-size:12pt"> students groups worldwide and the International Federation of Medical Students’ Associations.</span></li></ol><p style="font-size:12pt; line-height:115%; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><ol start="6" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal; line-height:115%; margin:0pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Pharmaceutical company GSK joined the campaign in February 2013 and committed to making information from clinical trials it ran from back to 2000 publicly avail</span><span style="font-family:'Times New Roman'; font-size:12pt">able. When they signed up, GSK said they owe this to the thousands of patients who took part in those trials. Other pharmaceutical companies such as Roche and LEO Pharma have also committed to sharing trial data. </span></li></ol><p style="font-size:12pt; line-height:115%; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><ol start="7" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal; line-height:115%; margin:0pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">The Declaration of Helsinki, which is the</span><span style="font-family:'Times New Roman'; font-size:12pt"> World Medical Association’s statement of principles for medical research involving people, states that every investigator running a clinical trial has an ethical obligation to register the trial before it starts; to give all the volunteers in the trial th</span><span style="font-family:'Times New Roman'; font-size:12pt">e option of being informed about the outcome and results; and to publish a summary of what was found in the trial. </span></li></ol><p style="font-size:12pt; line-height:115%; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><ol start="8" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal; line-height:115%; margin:0pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">The Health Research Authority has required since September 2013 that all clinical trials done in the UK need to be registered</span><span style="font-family:'Times New Roman'; font-size:12pt"> as a conditio</span><span style="font-family:'Times New Roman'; font-size:12pt">n</span><span style="font-family:'Times New Roman'; font-size:12pt"> for ethical approval. The HRA also asks that summary results be published. </span></li></ol><p style="font-size:12pt; line-height:115%; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><ol start="9" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal; line-height:115%; margin:0pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">The Health Select Committee said in its January 2013 report on NICE that “it should be neither legal nor ethical to withhold research data about pharmaceutical products which </span><span style="font-family:'Times New Roman'; font-size:12pt">are in clinical use.”</span></li></ol><p style="font-size:12pt; line-height:115%; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><ol start="10" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">The British Medical Association passed a motion in June 2013 stating that:</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></li></ol><p style="font-size:12pt; line-height:115%; margin:5pt 0pt 0pt 36pt; text-indent:36pt"><span style="font-family:'Times New Roman'; font-size:12pt">“(i) Selective non-publication of unflattering trial data is research misconduct; </span></p><p style="font-size:12pt; line-height:115%; margin:5pt 0pt 0pt 36pt; text-indent:36pt"><span style="font-family:'Times New Roman'; font-size:12pt">“(ii) Registered medical practitioners who give grounds to believe they h</span><span style="font-family:'Times New Roman'; font-size:12pt">ave been involved in such conduct should have their fitness to practice assessed by the GMC.” </span><span style="font-family:'Times New Roman'; font-size:12pt"> </span></p><p style="font-size:12pt; line-height:115%; margin:5pt 0pt 0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><ol start="11" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">We believe that th</span><span style="font-family:'Times New Roman'; font-size:12pt">e General Medical Council</span><span style="font-family:'Times New Roman'; font-size:12pt"> should have a role in ensuring that doctors working on clinical trials or who worked on a clinical trial in the pas</span><span style="font-family:'Times New Roman'; font-size:12pt">t on any treatment in current use ensure that the clinical trial has been registered and a summary of the findings is publicly available. </span></li></ol><p style="font-size:12pt; line-height:115%; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="font-size:12pt; line-height:115%; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic">December 2013 </span></p><p style="font-size:12pt; line-height:115%; margin:0pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:normal">&#xa0;</span></p><p style="margin:0pt; text-align:center"><span style="font-family:'Lucida Sans Unicode'; font-size:9pt">&#xa0;</span></p></div></body></html>